Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of bupropion in peripheral neuropathic pain
2019-000243-27Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Peripheral neuropathic pain, polyneuropathy, postherpetic neuralgia (PHN) and 1 more comparing Bupropion arm with Placebo arm (2 arms). Primary endpoint: Average weekly pain intensity. Started Jan 2019; status: completed.
02
Drugs
bupropion
03
Conditions
Peripheral neuropathic painpolyneuropathypostherpetic neuralgia (PHN)Neuralgia
Beyond the preview
Go deeper on 2019-000243-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000243-27.